JPX · 4502.T
Takeda Pharmaceutical Company Limited
¥6,651+¥180 (+2.78%)
Takeda Pharmaceutical Company Limited’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
Loading market information…
JPX · 4886.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
ASKA Pharmaceutical Holdings Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ASKA Pharmaceutical Holdings Co.,Ltd.’s forward annual dividend is ¥64 per share, paid semi-annual. The forward yield is 3.22% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
ASKA Pharmaceutical Holdings Co.,Ltd.’s next earnings report is currently expected on Nov 9, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow ASKA Pharmaceutical Holdings Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:11 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2024 | Nov 5, 2024 | ¥45 | ¥16.02B-0.07% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥6,651+¥180 (+2.78%)
Takeda Pharmaceutical Company Limited’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
¥3,436+¥18 (+0.53%)
Nippon Shinyaku Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.37% below the high.
¥3,520+¥60 (+1.73%)
Towa Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.6% below the high.
¥3,805+¥90 (+2.42%)
Kissei Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.5% below the high.
¥3,285+¥45 (+1.39%)
Mochida Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.15% below the high.
¥1,977+¥36 (+1.85%)
Zeria Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.78% below the high.
¥1,105+¥14 (+1.28%)
KYORIN Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.94% below the high.
¥1,870+¥39 (+2.13%)
Fuji Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.92% below the high.
